Lipid analogs and liposomes comprising same

US10730976B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10730976-B2
Application numberUS-201616064498-A
CountryUS
Kind codeB2
Filing dateDec 22, 2016
Priority dateDec 22, 2015
Publication dateAug 4, 2020
Grant dateAug 4, 2020

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A polymeric compound is disclosed herein, having the general formula I: wherein m, n, X, Y, Z and L are as defined herein. Further disclosed herein are lipid bilayers comprising at least one bilayer-forming lipid and the aforementioned polymeric compound, and liposomes comprising such a bilayer, as well as methods, uses and compositions utilizing such bilayers and/or liposomes for reducing a friction coefficient of a surface and/or for inhibiting biofilm formation.

First claim

Opening claim text (preview).

What is claimed is: 1. A polymeric compound having the general formula I: wherein: m is zero or a positive integer; n is an integer which is at least 1, wherein when X does not comprise a phosphate group, n is at least 2; X is a lipid moiety; Y is a backbone unit which forms a polymeric backbone; L is absent or is a linking moiety; and Z has the general formula II: wherein: A is a substituted or unsubstituted hydrocarbon; B is an oxygen atom or is absent; and R 1 -R 3 are each independently selected from the group consisting of hydrogen, alkyl, cycloalkyl, heteroalicyclic, aryl and heteroaryl, and wherein: a) said lipid is selected from the group consisting of a fatty acid, a monoglyceride, a glycerophospholipid, and a sphingolipid, and/or b) X has the general formula III: wherein: W 1 and W 2 are each independently selected from the group consisting of hydrogen, alkyl, alkenyl, alkynyl and acyl, wherein at least one of W 1 and W 2 is not hydrogen; J is —P(═O)(OH)—O— or absent; K is a substituted or unsubstituted hydrocarbon from 1 to 10 carbon atoms in length; M is a linking group selected from the group consisting of —O—, —S—, amino, sulfinyl, sulfonyl, phosphate, phosphonyl, phosphinyl, carbonyl, thiocarbonyl, urea, thiourea, carbamyl, thiocarbamyl, amido, carboxy, and sulfonamide, or absent; and Q is a substituted or unsubstituted hydrocarbon from 1 to 10 carbon atoms in length, or absent, wherein when M is absent, Q is also absent. 2. The polymeric compound of claim 1 , wherein Y is a substituted or unsubstituted alkylene unit. 3. The polymeric compound of claim 2 , wherein Y has the formula —CR 4 R 5 —CR 6 D-, wherein: when Y is a backbone unit which is not attached to said L or said Z, D is R 7 ; and when Y is a backbone unit which is attached to said L or said Z, D is a covalent bond or a linking group attaching Y to said L or said Z, said linking group being selected from the group consisting of —O—, —S—, alkylene, arylene, sulfinyl, sulfonyl, phosphate, phosphonyl, phosphinyl, carbonyl, thiocarbonyl, urea, thiourea, O-carbamyl, N-carbamyl, O-thiocarbamyl, N-thiocarbamyl, C-amido, N-amido, C-carboxy, O-carboxy, sulfonamido, and amino; and R 4 -R 7 are each independently selected from the group consisting of hydrogen, alkyl, alkenyl, alkynyl, cycloalkyl, aryl, heteroaryl, heteroalicyclic, halo, hydroxy, alkoxy, aryloxy, thiohydroxy, thioalkoxy, thioaryloxy, sulfinyl, sulfonyl, cyano, nitro, azide, azo, phosphate, phosphonyl, phosphinyl, oxo, carbonyl, thiocarbonyl, urea, thiourea, O-carbamyl, N-carbamyl, O-thiocarbamyl, N-thiocarbamyl, C-amido, N-amido, C-carboxy, O-carboxy, sulfonamido, and amino. 4. The polymeric compound of claim 1 , wherein A is a substituted or unsubstituted hydrocarbon from 1 to 4 carbon atoms in length. 5. The polymeric compound of claim 1 , wherein n is at least 3. 6. The polymeric compound of claim 1 , wherein at least a portion of said Y, said L and/or said Z comprise at least one targeting moiety. 7. The polymeric compound of claim 1 , wherein said lipid is selected from the group consisting of a fatty acid, a monoglyceride, a glycerophospholipid, and a sphingolipid. 8. The polymeric compound of claim 1 , wherein X has said general formula III. 9. The polymeric compound of claim 8 , wherein at least one of W 1 and W 2 is alkyl, alkenyl, alkynyl or acyl, being from 10 to 30 carbon atoms in length. 10. A lipid bilayer comprising at least one bilayer-forming lipid and the polymeric compound of claim 1 . 11. A liposome comprising at least one lipid bilayer according to claim 10 . 12. The liposome of claim 11 , further comprising at least one functional moiety or agent, bound to a surface of the liposome and/or within a lipid bilayer and/or core of the liposome. 13. A lubricant composition comprising liposomes according to claim 11 and a carrier. 14. The lubricant composition of claim 13 , being for lubricating a physiological surface, wherein said carrier is a physiologically acceptable carrier. 15. A method of reducing a friction coefficient of a surface, the method comprising contacting the surface with liposomes according to claim 11 . 16. The method of claim 15 , further comprising contacting the surface with a water-soluble polymer. 17. The method of claim 15 , wherein said surface is a physiological surface, the method being effected by contacting the surface with a composition comprising said liposomes and a physiologically acceptable carrier. 18. A method of treating a synovial joint disorder associated with an increased friction coefficient of an articular surface in the synovial joint in a subject in need thereof, the method comprising administering to the subject the liposome of claim 11 . 19. A method of inhibiting biofilm formation on a surface of a substrate, the method comprising contacting the substrate with a composition which comprises liposomes according to claim 11 . 20. An article of manufacture comprising a composition-of-matter, the composition-of-matter comprising a substrate coated, on at least a portion of a surface thereof, by a lipid bilayer according to claim 10 .

Assignees

Inventors

Classifications

  • Atom Transfer Radical Polymerization [ATRP] or reverse ATRP · CPC title

  • C08F130/02Primary

    containing phosphorus · CPC title

  • with hydroxyalkyl compounds without further substituents on alkyl · CPC title

  • the form being a liposome · CPC title

  • obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10730976B2 cover?
A polymeric compound is disclosed herein, having the general formula I: wherein m, n, X, Y, Z and L are as defined herein. Further disclosed herein are lipid bilayers comprising at least one bilayer-forming lipid and the aforementioned polymeric compound, and liposomes comprising such a bilayer, as well as methods, uses and compositions utilizing such bilayers and/or …
Who is the assignee on this patent?
Yeda Res & Dev
What technology area does this patent fall under?
Primary CPC classification C08F130/02. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Aug 04 2020 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).